ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Oks Noncompetitive Contract Concepts

November 11, 1983

NCAB Subcommittee Approves Compromise On Changes In Organ Site Program

April 9, 1982

Soybean Studies, Computing Support Recompetition Ok’d

November 9, 1990

ACS Awards Professorships To Brugge, Hanahan, Samson; Renews Verma, Wigler.

February 9, 2001

In Brief: Ford Decides Against Asking For Recision Of NCI Funds After Congress Overrides Verto

October 8, 1976

NIH Alternative Medicine Office Releases RFA For Grant Awards

April 9, 1993